ArticleInternational journal of retina and vitreous2025

Aflibercept, ranibizumab, and bevacizumab for macular neovascularization secondary to age-related macular degeneration: a retrospective OCT-angiography study.

Marco Lombardo et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.